多发性硬化症中冷漠的临床和放射学相关性
Francesco Tazza1,2, Simona Schiavi1,2, Elisa Leveraro3
1Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
概括
多发性硬化症 (MS) 的冷漠与更大的残疾,抑郁,焦虑和疲劳有关. 脑部成像显示前部区域的微观结构损伤和白质通道有助于MS患者的冷漠.
科学领域:
- 神经学 神经学
- 神经成像是一种神经成像.
- 神经心理学 神经心理学
背景情况:
- 漠不关心与神经系统疾病中的前-皮功能障碍有关.
- 多发性硬化症 (MS) 中无动于衷的临床和MRI相关性尚未得到充分理解.
研究的目的:
- 评估与MS (PwMS) 患者的冷漠相关的临床变量.
- 通过扩散张力成像 (DTI) 来研究前上灰质 (GM) 和白质 (WM) 的微结构完整性.
主要方法:
- 123名PwMS患者接受了神经/神经心理评估和3T-MRI.
- 评估的临床变量包括EDSS,AES-S,HADS和MFIS.
- 评估了GM和WM的微观结构完整性,使用DTI指标在前-三角形区域.
主要成果:
- 无动于衷的PwMS (32.5%) 的教育程度较低,HADS/MFIS得分较高,WM损伤量较大.
- 在前端PFC子区域和尾状核中观察到显著的DTI度量差异.
- 在右侧环带和左侧条纹-前视管道中发现了变化.
结论:
- 在PwMS中的冷漠与增加的残疾,抑郁,焦虑,疲劳和教育水平较低有关.
- 额叶皮质,尾状皮质和前-状皮质的微观结构损伤是MS中无动于衷的基础.
相关概念视频
Negative and Cognitive Symptoms of Schizophrenia
49
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
49
Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492
Myasthenia Gravis: Diagnostic Tests
883
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
883
Parkinson's Disease: Overview
556
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
556
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K


